Physician

Joshua Garren, MD

According to 2025 Medicare claims, Joshua Garren, MD (NPI: 1437215886) practices radiation oncology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (NPI: 1962876045; TIN: 383983999) and primary practice location at 74146-6236.

Garren's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 485 traditional Medicare patients, billed 27,825 HCPCS/CPT codes, and received $1,759,185 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 198 prescription claims across 100 beneficiaries totaling $4,620 in drug costs, led by Lidocaine Hcl Viscous (Lidocaine Hcl). Open Payments data shows 4 records totaling $90. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $960,754 to $1,759,185. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $960,754 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $997,747 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,655,113 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,986,984 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,525,484 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,612,785 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,491,651 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,651,856 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,048,661 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,759,185 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151997,240$960,754
20162797,228$997,747
201733227,667$1,655,113
20181,568107,518$2,986,984
201980193,016$2,525,484
202082794,738$2,612,785
202189398,743$2,491,651
202278491,333$2,651,856
202364786,177$2,048,661
202448527,825$1,759,185

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$10K$20K2015 Drug cost: $8,565 (USD; Tot_Drug_Cst)2016 Drug cost: $12,360 (USD; Tot_Drug_Cst)2017 Drug cost: $10,145 (USD; Tot_Drug_Cst)2018 Drug cost: $20,002 (USD; Tot_Drug_Cst)2019 Drug cost: $18,499 (USD; Tot_Drug_Cst)2020 Drug cost: $14,431 (USD; Tot_Drug_Cst)2021 Drug cost: $12,962 (USD; Tot_Drug_Cst)2022 Drug cost: $8,842 (USD; Tot_Drug_Cst)2023 Drug cost: $8,977 (USD; Tot_Drug_Cst)2024 Drug cost: $4,620 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201572175$8,565
201679213$12,360
2017108303$10,145
2018117376$20,002
2019134420$18,499
2020125342$14,431
2021116339$12,962
2022122279$8,842
2023122258$8,977
2024100198$4,620

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session2061,577$244
77427Radiation treatment management, 5 treatment sessions143395$141
77334Design and construction of complex radiation treatment device93153$89
77014Ct guidance for insertion of radiation therapy fields2201,595$85
77336Continuing radiation therapy consultation per week214401$61

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Lidocaine Hcl ViscousLidocaine Hcl12173$469
Tamsulosin HclTamsulosin Hcl421,500$450
SsdSilver Sulfadiazine14349$401
HydrocortisoneHydrocortisone24863$211

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$90Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joshua Garren, MD?

Tedicare shows public-source Medicare data for Joshua Garren, MD (NPI 1437215886), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Garren, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua Garren, MD?

Joshua Garren, MD is linked to OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (billing NPI 1962876045) in the available physician profile data.

Does Joshua Garren, MD have Open Payments data?

Joshua Garren, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.